MR编号 | FR/V/0237/001 |
---|
药品名称 | CANIGEN DHPPi/L |
---|
活性成分 | - canine adenovirus 4.0 log10 CCID50
- canine distemper virus 3.15 log10 CCID50
- canine parainfluenza virus 5.0 log10 CCID50
- canine parvovirus 5.0 log10 CCID50
- leptospira interrogans serogroup canicola 8.33 8log10 bact/mL
- leptospira interrogans serogroup icterohaemorragiae 8.33 8log10 bact/mL
|
---|
剂型 | Powder and solvent for suspension for injection |
---|
上市许可持有人 | VIRBAC |
---|
参考成员国 - 产品名称 | France (FR) CANIGEN CHPPi/L |
---|
互认成员国 - 产品名称 | - Greece (GR)
- Sweden (SE)
- Estonia (EE)
- Poland (PL)
- United Kingdom (Northern Ireland) (XI)
Canigen DHPPi/L - Czechia (CZ)
- Slovakia (SK)
- Slovenia (SI)
- Romania (RO)
- Norway (NO)
- Latvia (LV)
Canigen DHPPi/L - Lithuania (LT)
- Croatia (HR)
- Finland (FI)
- Cyprus (CY)
- Bulgaria (BG)
- Italy (IT)
- Portugal (PT)
- Spain (ES)
- Austria (AT)
- Ireland (IE)
- Luxembourg (LU)
- Netherlands (NL)
- Belgium (BE)
Canigen DHPPi/L - Denmark (DK)
- Germany (DE)
Canigen DHPPi/L - Hungary (HU)
|
---|
许可日期 | 2011/12/16 |
---|
最近更新日期 | 2024/09/05 |
---|
药物ATC编码 | - QI07AI02 live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira
|
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|